SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-069021
Filing Date
2018-03-02
Accepted
2018-03-02 17:02:03
Documents
6
Period of Report
2018-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d304928d8k.htm 8-K 30738
2 EX-10.1 d304928dex101.htm EX-10.1 812985
3 EX-10.2 d304928dex102.htm EX-10.2 87847
4 EX-10.3 d304928dex103.htm EX-10.3 91084
5 EX-99.1 d304928dex991.htm EX-99.1 6499
6 GRAPHIC g304928tem.jpg GRAPHIC 2990
  Complete submission text file 0001193125-18-069021.txt   1034824
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 18663008
SIC: 2834 Pharmaceutical Preparations